DK575077A - Fremgangsmaade til fremstilling af 0-alkylerede oximer - Google Patents
Fremgangsmaade til fremstilling af 0-alkylerede oximerInfo
- Publication number
- DK575077A DK575077A DK575077A DK575077A DK575077A DK 575077 A DK575077 A DK 575077A DK 575077 A DK575077 A DK 575077A DK 575077 A DK575077 A DK 575077A DK 575077 A DK575077 A DK 575077A
- Authority
- DK
- Denmark
- Prior art keywords
- alkyled
- oximes
- procedure
- preparation
- alkyled oximes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Epoxy Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19762658762 DE2658762A1 (de) | 1976-12-24 | 1976-12-24 | Neue o-alkylierte oxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| DE2658762 | 1976-12-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK575077A true DK575077A (da) | 1978-06-25 |
| DK146886B DK146886B (da) | 1984-01-30 |
| DK146886C DK146886C (da) | 1984-07-09 |
Family
ID=5996577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK575077A DK146886C (da) | 1976-12-24 | 1977-12-22 | Analogifremgangsmaade til fremstilling af basisk substituerede o-propylerede oximer eller fysiologisk acceptable syreadditionssalte deraf |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4358450A (da) |
| JP (2) | JPS6044307B2 (da) |
| AT (1) | AT359069B (da) |
| AU (1) | AU514855B2 (da) |
| BE (1) | BE862302A (da) |
| CA (1) | CA1105019A (da) |
| CH (2) | CH639654A5 (da) |
| DE (1) | DE2658762A1 (da) |
| DK (1) | DK146886C (da) |
| ES (3) | ES465203A1 (da) |
| FI (1) | FI773902A (da) |
| FR (1) | FR2375224A1 (da) |
| GB (1) | GB1542793A (da) |
| GR (1) | GR71598B (da) |
| IT (1) | IT1088927B (da) |
| NL (1) | NL7714057A (da) |
| SE (1) | SE433493B (da) |
| ZA (1) | ZA777584B (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2651083A1 (de) * | 1976-11-09 | 1978-05-18 | Hoechst Ag | Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung |
| US4780466A (en) * | 1988-03-17 | 1988-10-25 | Hoechst-Roussel Pharmaceuticals, Inc. | Arylpiperazinylalkoxy derivatives of cyclic imides |
| US5229404A (en) * | 1988-05-18 | 1993-07-20 | Novo Nordisk A/S | Azacyclic carboxylic acid derivatives and their preparation and use |
| US5214054A (en) * | 1988-05-18 | 1993-05-25 | Novo Nordisk A/S | Azacyclic carboxylic acid derivatives and their preparation and use |
| JP2765876B2 (ja) * | 1988-10-24 | 1998-06-18 | 科研製薬株式会社 | ピリジルケトオキシムエーテル誘導体 |
| US5665756A (en) * | 1994-08-03 | 1997-09-09 | Hoechst Marion Roussel, Inc. | Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders |
| US6089056A (en) * | 1997-06-25 | 2000-07-18 | Mitsui Kinzoku Kogyo Kabushiki Kaisha | Structure for mounting a metallic pin into a resin part |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3060177A (en) * | 1957-11-11 | 1962-10-23 | Ciba Geigy Corp | O-(aminoalkyl)oxime derivatives of heterocyclic aldehydes and ketones |
| GB842968A (en) * | 1957-11-11 | 1960-08-04 | Ciba Ltd | New o-aminoalkyl oximes |
| US3692835A (en) * | 1967-04-05 | 1972-09-19 | Jan Van Dijk | Pharmacologically active amino-ethyl oximes |
| GB1192995A (en) * | 1967-04-12 | 1970-05-28 | Egyt Gyogyszervegyeszeti Gyar | Formimino Ethers |
| FR2187311B1 (da) * | 1972-06-02 | 1975-06-20 | Bouchara Emile | |
| DE2235597A1 (de) * | 1972-07-20 | 1974-01-31 | Boehringer Mannheim Gmbh | 1-eckige klammer auf 3-(5,6,7,8tetrahydronaphth-1-yl-oxy) -propyl eckige klammer zu -piperazin-derivate und verfahren zu ihrer herstellung |
| US4000274A (en) * | 1972-12-23 | 1976-12-28 | Boehringer Ingelheim Gmbh | Pharmaceutical compositions containing an n-aryl-n'-(phenyl-or-phenoxy-alkyl)-piperazine and method of use |
| GB1474316A (en) * | 1975-02-12 | 1977-05-25 | Seperic | O-aminoalkyl oximes |
| US4083978A (en) * | 1976-01-27 | 1978-04-11 | Egyt Gyogyszervegyeszeti Gyar | Oxime ethers |
-
1976
- 1976-12-24 DE DE19762658762 patent/DE2658762A1/de not_active Withdrawn
-
1977
- 1977-12-19 NL NL7714057A patent/NL7714057A/xx not_active Application Discontinuation
- 1977-12-19 ES ES465203A patent/ES465203A1/es not_active Expired
- 1977-12-21 ZA ZA00777584A patent/ZA777584B/xx unknown
- 1977-12-21 GB GB53221/77A patent/GB1542793A/en not_active Expired
- 1977-12-21 AU AU31814/77A patent/AU514855B2/en not_active Expired
- 1977-12-22 AT AT924577A patent/AT359069B/de not_active IP Right Cessation
- 1977-12-22 FI FI773902A patent/FI773902A/fi not_active Application Discontinuation
- 1977-12-22 GR GR55043A patent/GR71598B/el unknown
- 1977-12-22 SE SE7714684A patent/SE433493B/sv unknown
- 1977-12-22 DK DK575077A patent/DK146886C/da active
- 1977-12-23 FR FR7739022A patent/FR2375224A1/fr active Granted
- 1977-12-23 BE BE183830A patent/BE862302A/xx not_active IP Right Cessation
- 1977-12-23 CA CA293,840A patent/CA1105019A/en not_active Expired
- 1977-12-23 IT IT31207/77A patent/IT1088927B/it active
- 1977-12-23 CH CH1598277A patent/CH639654A5/de not_active IP Right Cessation
- 1977-12-23 JP JP52155478A patent/JPS6044307B2/ja not_active Expired
-
1978
- 1978-04-19 ES ES468940A patent/ES468940A1/es not_active Expired
- 1978-04-19 ES ES468939A patent/ES468939A1/es not_active Expired
-
1979
- 1979-02-28 JP JP54022055A patent/JPS5910661B2/ja not_active Expired
- 1979-08-06 US US06/063,810 patent/US4358450A/en not_active Expired - Lifetime
-
1982
- 1982-12-10 CH CH718882A patent/CH639649A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES468940A1 (es) | 1978-12-16 |
| NL7714057A (nl) | 1978-06-27 |
| BE862302A (fr) | 1978-06-23 |
| DE2658762A1 (de) | 1978-06-29 |
| GB1542793A (en) | 1979-03-28 |
| IT1088927B (it) | 1985-06-10 |
| ZA777584B (en) | 1978-11-29 |
| JPS6044307B2 (ja) | 1985-10-02 |
| CH639654A5 (de) | 1983-11-30 |
| FI773902A (fi) | 1978-06-25 |
| FR2375224B1 (da) | 1982-04-02 |
| ES468939A1 (es) | 1978-12-16 |
| JPS5910661B2 (ja) | 1984-03-10 |
| GR71598B (da) | 1983-06-17 |
| US4358450A (en) | 1982-11-09 |
| SE433493B (sv) | 1984-05-28 |
| JPS54135774A (en) | 1979-10-22 |
| AU3181477A (en) | 1979-06-28 |
| AU514855B2 (en) | 1981-03-05 |
| AT359069B (de) | 1980-10-27 |
| ATA924577A (de) | 1980-03-15 |
| JPS53111076A (en) | 1978-09-28 |
| FR2375224A1 (fr) | 1978-07-21 |
| DK146886B (da) | 1984-01-30 |
| CA1105019A (en) | 1981-07-14 |
| SE7714684L (sv) | 1978-06-25 |
| DK146886C (da) | 1984-07-09 |
| ES465203A1 (es) | 1978-09-16 |
| CH639649A5 (de) | 1983-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK30277A (da) | Fremgangsmade til fremstilling af substituerede phenylamidiner | |
| DK347077A (da) | Fremgangsmade til fremstilling af d (-)-3-hydroxysmorsyre | |
| DK377A (da) | Fremgangsmade til fremstilling af n-phosphonomethyl-glycin | |
| DK244577A (da) | Fremgangsmade til fremstilling af hydantoinderivater | |
| DK46777A (da) | Fremgangsmade til fremstilling af meta-aryloxybenzaldehyder | |
| DK276177A (da) | Fremgangsmade til fremstilling af gammapyron-forbindelser | |
| DK577977A (da) | Fremgangsmaade til fremstilling af alfa-l-aspartyl-l-phenylalanin-methyler | |
| DK339677A (da) | Fremgangsmade til fremstilling af 2-benzylpyrrolidiner | |
| DK587077A (da) | Fremgangsmaade til fremstilling af estere | |
| DK144377A (da) | Fremgangsmade til fremstilling af acylcyanider | |
| DK184377A (da) | Fremgangsmade til fremstilling af indazolyl-(4)-oxy-propanolaminer | |
| DK88777A (da) | Fremgangsmade til fremstilling af substituerede azapuriner | |
| DK233477A (da) | Fremgangsmade til fremstilling af antiotiske midler | |
| DK271377A (da) | Fremgangsmade til fremstilling af substituerede arylacetamidocephalosporiner | |
| DK575077A (da) | Fremgangsmaade til fremstilling af 0-alkylerede oximer | |
| DK216977A (da) | Fremgangsmade til fremstilling af imidazobenzoxaziner | |
| DK144277A (da) | Fremgangsmade til fremstilling af acylcyanider | |
| DK146277A (da) | Fremgangsmade til fremstilling af 2-chlornicotinsyre | |
| DK524977A (da) | Fremgangsmaade til fremstilling af 6-aminopencillansyre | |
| DK73277A (da) | Fremgangsmaade til fremstilling af sulfonylbenzimidazoler | |
| DK575277A (da) | Fremgangsmaade til fremstilling af basisk substituerede 0-propyloximer | |
| DK196577A (da) | Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester | |
| DK538977A (da) | Fremgangsmaade til fremstilling af 17alfa-hydroxy-21-acetoxy-progesteron | |
| DK582177A (da) | Fremgangsmaade til fremstilling af halogenacylamider | |
| DK123177A (da) | Fremgangsmade til fremstilling af 7-alkoxy-3-chlormethyl-3-cephem-forbindelser |